NCT00116740View on ClinicalTrials.gov

Safety and Efficacy of APD356 in the Treatment of Obesity

PHASE2CompletedINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

June 30, 2005

Study Completion Date

November 30, 2005

Conditions

Obesity

Interventions

DRUG

APD356

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors

lead

Eisai Inc.

INDUSTRY

NCT00116740 - Safety and Efficacy of APD356 in the Treatment of Obesity | Biotech Hunter | Biotech Hunter